Skip to main content
Clinical Trials/CTRI/2018/02/012197
CTRI/2018/02/012197
Completed
Phase 4

Dexmedetomidine infusion for prevention of emergence agitation after nasal surgery

Tejesh CA0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Health patients without any comorbidities
Sponsor
Tejesh CA
Enrollment
100
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 1, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Tejesh CA

Eligibility Criteria

Inclusion Criteria

  • American Society of Anaesthesiologists (ASA)grade 1 and 2
  • Patients undergoing nasal surgery under general anaesthesia and requiring nasal packing after surgery

Exclusion Criteria

  • Known or suspected allergy to α2 adrenergic agonists.
  • Use of monoamine oxidase inhibitors, adrenergic blocking agents or clonidine.
  • Uncontrolled hypertension and Diabetes mellitus.
  • Heart block greater than first degree.
  • Cognitive impairment.
  • Chronic use of antipsychotic medications.
  • Kidney or liver disease.
  • Body Mass index \>\=30kg/m²

Outcomes

Primary Outcomes

Not specified

Similar Trials